Dynavax Technologies Corporation, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on ... Dec 11
The results of this clinical trial are expected to be available by February 2021 ... Nov 16
-Advertisements-